Skip to main content
. 2023 Nov 15;73(Suppl 2):222–226. doi: 10.1007/s13224-023-01847-8

Table 2.

Outcomes measured for safety and efficacy

Overall (n = 1713) Group 1: primiparas (n = 523) Group 2: multiparas (n = 656) Group 3: grand multiparas (n = 534) p value
Normal vaginal delivery 1452 (84.8%) 360 (68.8%) 592 (90.2%) 500 (93.6%)

 < 0.001

1 ≠ 2,3

Instrumental Delivery 188 (11%) 119 (22.8%) 48 (7.3%) 21 (3.9%)

0.017

1 ≠ 2 ≠ 3

Cesarean delivery 73 (4.3%) 44 (8.4%) 16 (2.4%) 13 (2.4%)

 < 0.001

1 ≠ 2,3

Blood transfusion rate, n (%) 18 (1) 10 (1.8) 3 (0.5) 5 (0.9) 0.057
Rate of APGAR 5’ minutes < 7, n (%) 9 (0.5) 2 (0.4) 4 (0.6) 3 (0.6) 0.840
Rate of UA pH < 7.1, n (%)a 11 (7.7) 9 (10.1) 1 (3.0) 1 (5.0) 0.380
Time to delivery, hrb 22.0 (21.0–22.9) 29.7 (27.8–31.7) 18.6 (17.3–20.0) 18.5 (17.0–20.1)

 < 0.001

1 ≠ 2,3

Deliveries within 24 h, n (%) 1181 (67.5) 294 (53.9) 486 (73.0) 401 (74.5)

 < 0.001

1 ≠ 2,3

Deliveries in 24–48 h, n (%) 384 (22) 162 (29.7) 129 (19.4) 93 (17.3)

 < 0.001

1 ≠ 2,3

Deliveries after more than 48 h, n (%) 184 (10.5) 89 (16.3) 51 (7.7) 44 (8.2)

 < 0.001

1 ≠ 2,3

a = UA pH was taken only in deliveries with suspected fetal distress, instrumental deliveries and cesarean deliveries. Percentages are related to total number of pH taken

b = Data are given with 95% confidence interval for mean in the parenthesis